News
Eidos Therapeutics, Inc., today announced the initiation and design of its pivotal global Phase 3 trial (ATTRibute-CM) of AG10 in patients with Transthyretin (TTR)…
Help raise money and awareness for a rare disease that took the life of longtime ski instructor Bill Cunningham, who had a more than 30-year affiliation with Cannon…
Join a Live Webinar Event on "Progress in Amyloidosis Research: Where Are We Now?" conducted by the Amyloidosis Foundationexternal link, opens in a new tab.…